Pediatrix Medical Group (NYSE:MD) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Pediatrix Medical Group (NYSE:MD) from a buy rating to a hold rating in a research report report published on Thursday.

Several other analysts also recently commented on the stock. Mizuho raised their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft boosted their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a report on Monday, November 4th. Jefferies Financial Group boosted their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Finally, UBS Group raised their target price on shares of Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research note on Tuesday, November 5th. Five research analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $16.10.

Pediatrix Medical Group Trading Up 1.4 %

Shares of Pediatrix Medical Group stock opened at $14.96 on Thursday. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $16.41. The company’s fifty day simple moving average is $12.93 and its 200-day simple moving average is $10.05. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. The stock has a market capitalization of $1.28 billion, a PE ratio of -4.89, a P/E/G ratio of 2.10 and a beta of 1.55.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. The company had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. During the same period in the previous year, the business earned $0.29 earnings per share. Pediatrix Medical Group’s quarterly revenue was up .9% compared to the same quarter last year. As a group, equities analysts anticipate that Pediatrix Medical Group will post 1.26 earnings per share for the current year.

Insider Transactions at Pediatrix Medical Group

In other news, Director Laura A. Linynsky sold 7,000 shares of the company’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $11.16, for a total transaction of $78,120.00. Following the sale, the director now directly owns 30,805 shares in the company, valued at approximately $343,783.80. This represents a 18.52 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James D. Swift sold 11,100 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $10.79, for a total transaction of $119,769.00. Following the completion of the transaction, the chief executive officer now directly owns 170,001 shares of the company’s stock, valued at approximately $1,834,310.79. The trade was a 6.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 53,808 shares of company stock valued at $751,277 in the last ninety days. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Pediatrix Medical Group

Institutional investors have recently bought and sold shares of the stock. Quest Partners LLC lifted its stake in Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after purchasing an additional 622 shares during the last quarter. nVerses Capital LLC bought a new position in Pediatrix Medical Group in the 2nd quarter valued at $31,000. Innealta Capital LLC purchased a new stake in Pediatrix Medical Group in the second quarter worth $33,000. Quarry LP lifted its position in shares of Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its position in shares of Pediatrix Medical Group by 47.2% during the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company’s stock worth $36,000 after purchasing an additional 1,524 shares during the last quarter. 97.71% of the stock is currently owned by institutional investors.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.